Velpatasvir CAS 1377049-84-7: Comprehensive Product Guide
Table of Contents
- 1. Product Overview & Specifications
- 2. Key Applications & Therapeutic Uses
- 3. Usage Guidelines & Best Practices
- 4. Implementation Case Studies
- 5. Verified Client Success Stories
- 6. Request Customized Solutions
1. Product Overview & Specifications
| Parameter | Velpatasvir CAS 1377049-84-7 | Comparable HCV Agents |
|---|---|---|
| CAS Number | 1377049-84-7 | N/A |
| Molecular Formula | C₄₉H₅₄N₈O₈ | Varies by compound |
| Purity Grade | ≥99% HPLC | 98-99% typical |
| Storage Conditions | -20°C sealed | Room temp alternatives |
2. Key Applications & Therapeutic Uses
Velpatasvir (CAS 1377049-84-7) serves as critical component in:
- HCV genotype 1-6 treatment regimens
- Fixed-dose combination therapies
- Pan-genotypic antiviral formulations
3. Usage Guidelines & Best Practices
Recommended implementation protocols:
| Use Case | Dosage Form | Synergistic Agents |
|---|---|---|
| Treatment-naive patients | Oral tablets | Sofosbuvir combination |
| Compensated cirrhosis | Modified release | Ribavirin adjunct |
4. Implementation Case Studies
Case 1: Urban Hospital Network
Implemented Velpatasvir-based therapy across 12 facilities…
Case 2: Clinical Trial Success
Phase III trials showing 98% SVR12 rates…
5. Verified Client Success Stories
Client 1: India-Based Pharma Manufacturer
- Volume: 150kg annual procurement
- Application: Generic HCV treatment
- Outcome: 40% production cost reduction
Client 2: Brazilian Research Consortium
- Volume: 25kg clinical trial supply
- Application: Pediatric formulation R&D
- Outcome: Successful phase II completion
6. Request Customized Solutions
Contact our technical specialists:
Email: info@vivalr.com
Phone: (86) 15866781826
Request specific documentation:
- Certificates of Analysis (CoA)
- Regulatory Support Packages
- Custom Synthesis Options



评论
目前还没有评论。